3 d. ago Watch Cheap Valuations, DeepSeek Make China Attractive: CLSA

Watch Cheap Valuations, DeepSeek Make China Attractive: CLSA  Bloomberg.com

Politics

3 d. ago Starbucks China valued at about US$5 billion by bidders, sources say

Most of the bidders seeking to buy a portion of Starbucks’ China operations have submitted offers valuing the business at as much as US$5 billion, said two people with knowledge of the discussions. That would make a potential deal one of the most valuable China unit divestments by a global consumer company in recent years. The offers, which have not been reported previously, would let Starbucks push ahead with the sale in a market where it faces sluggish growth and stiff competition from local...

Economics

3 d. ago Starbucks Said To Have Landed $5B Valuation For China Business Amid Intense Battle With Luckin Coffee

Starbucks Said To Have Landed $5B Valuation For China Business Amid Intense Battle With Luckin Coffee  Stocktwits

Economics

3 d. ago Exclusive: Starbucks China valued at about $5 billion by bidders, sources say

Exclusive: Starbucks China valued at about $5 billion by bidders, sources say  Reuters

Economics

3 d. ago Nvidia: Bulls Ignore Valuation, Bears Ignore China (NASDAQ:NVDA)

Nvidia: Bulls Ignore Valuation, Bears Ignore China (NASDAQ:NVDA)  Seeking Alpha

Politics

1 week ago Value of small packages sent from China to UK more than doubles

Value of small packages sent from China to UK more than doubles  BBC

Politics

1 week ago Ping An interim profit misses estimates as China’s economy sputters

The first-half profit of China’s most valuable insurance company missed analysts’ estimates, as one-off revaluations of investments eroded the increasing sales of life and health products by Ping An Insurance (Group). Interim net profit fell 8.8 per cent to 68.05 billion yuan (US$9.50 billion) from a year earlier, missing a 4.4 per cent increase that was expected by Bloomberg’s consensus estimate. The value of new business in Ping An’s life and health insurance divisions, a key measure of future...

Economics

2 w. ago What next for market as China’s Puer tea bubble comes off the boil?

Aromatic infusions of fermented and aged Puer tea have been popular in China for centuries, but later generations of enthusiasts came to value its investment potential even more, dubbing it a “drinkable antique”. Chinese entrepreneurs and members of the country’s growing middle class long regarded the tea, produced in Yunnan province, as a wealth preservation investment rivalling stocks and real estate, but the market has come off the boil recently as the economy slows and investor appetite...

Politics

2 w. ago Hong Kong water scandal: tougher vetting of tender bidders needed, lawmakers say

Hong Kong lawmakers have called for tougher vetting of bidders for government tenders, accusing authorities of accepting information submitted by companies at face value after awarding a HK$52.9 million (US$8.8 million) bottled water contract to a firm suspected of deception. The calls for stricter background checks came as a senior official apologised for the first time over the growing procurement scandal, which came to light at the weekend after the government was forced to terminate a...

Politics

2 w. ago Hong Kong’s rally has room to run on ‘reasonable’ valuations: Templeton

Hong Kong stocks remain favourable, as attractive valuations and easing tariff uncertainty have enhanced the predictability of corporate earnings on the city’s stock market, according to US fund manager Franklin Templeton. The firm, which manages US$1.5 trillion of assets worldwide, was “constructive” on Hong Kong and mainland China’s stock markets, as the valuations remained reasonable and Beijing had introduced supportive policies, said Ferdinand Cheuk, portfolio manager at Templeton Global...

Politics

2 w. ago China private equity secondary deals to surge on rising supply, cheaper valuations

China private equity secondary deals to surge on rising supply, cheaper valuations  Reuters

Economics

2 w. ago How Beijing is Deepening Stakes in Kazakhstan’s Energy Value Chain

How Beijing is Deepening Stakes in Kazakhstan’s Energy Value Chain  The China-Global South Project

Politics

2 w. ago Labubu phenomenon drives Pop Mart’s record interim sales, earnings

Pop Mart established itself as the world’s most valuable toy producer and exporter of China’s “soft power” after the global phenomenon of its Labubu plush toys and figurines drove overseas revenue to soar fivefold in the first half. Online and in-store revenue outside mainland China jumped to 5.59 billion yuan (US$778 million) in the first six months, making up about 40 per cent of the Beijing-based group’s total interim sales of 13.88 billion yuan, which beat analysts’ estimates, Pop Mart said...

Politics

3 w. ago Chinese pharma firms Hengrui, Hansoh expected to post strong first

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits, buoyed by novel drug roll-outs and revenue from technology licensing. On August 21, Hengrui, China’s largest drug maker by market value, is expected to say its net profit for the first half rose 40 per cent from a year earlier to 4.1 billion yuan (US$570.8 million), with revenue up 9 per cent to 15.7 billion yuan, according to analysts’...

Politics

3 w. ago Innogen’s shares almost quadruple in Hong Kong trading debut

Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen’s shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price of HK$18.68 despite a declining market. The city’s benchmark Hang Seng index opened almost 1 per cent lower. “We are taking a...

Politics

3 w. ago Innogen Pharmaceutical’s shares soar in Hong Kong trading debut

Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen’s shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price of HK$18.68 despite a declining market. The stock closed at HK$57.25, while the city’s benchmark Hang Seng Index fell 1 per...

Politics

3 w. ago Exclusive: China's aland Health seeking buyers at over $1.5 billion valuation, sources say

Exclusive: China's aland Health seeking buyers at over $1.5 billion valuation, sources say  Reuters

Economics

4 w. ago Nestlé: Navigating China's Challenges While Offering Attractive Valuation in a Fragmented Global Food Sector

Nestlé: Navigating China's Challenges While Offering Attractive Valuation in a Fragmented Global Food Sector  AInvest

Politics

4 w. ago Amid China tensions, what ‘valuable lessons’ can Philippines learn from Poland?

With Poland bracing for potential Russian aggression and the Philippines contending with sustained tensions with Beijing in the South China Sea, analysts say the two countries may find strategic common ground – not just in their geopolitical outlooks, but also in their shared aspirations as “emerging middle powers”. Warsaw’s dramatic ramp-up in defence spending and its uncompromising stance against Moscow’s provocations have drawn the attention of Filipino security analysts, some of whom see...

Events